Encephalitis

Last updated
Encephalitis
Hsv encephalitis.jpg
MRI scan image shows high signal in the temporal lobes and right inferior frontal gyrus in someone with herpes simplex encephalitis.
Specialty Neurology, infectious disease
Symptoms Headache, fever, confusion, stiff neck, vomiting [1]
Complications Seizures, trouble speaking, memory problems, problems hearing [1]
DurationWeeks to months for recovery [1]
Types Herpes simplex, West Nile, rabies, Eastern equine, others [2]
CausesInfection, autoimmune, certain medication, unknown [2]
Diagnostic method Based on symptoms, supported by blood tests, medical imaging, analysis of cerebrospinal fluid [2]
Treatment Antiviral medication, anticonvulsants, corticosteroids, artificial respiration [1]
Prognosis Variable [1]
Frequency4.3 million (2015) [3]
Deaths150,000 (2015) [4]

Encephalitis is inflammation of the brain. [5] The severity can be variable with symptoms including reduction or alteration in consciousness, headache, fever, confusion, a stiff neck, and vomiting. [1] [6] Complications may include seizures, hallucinations, trouble speaking, memory problems, and problems with hearing. [1]

Contents

Causes of encephalitis include viruses such as herpes simplex virus and rabies virus as well as bacteria, fungi, or parasites. [1] [2] Other causes include autoimmune diseases and certain medications. [2] In many cases the cause remains unknown. [2] Risk factors include a weak immune system. [2] Diagnosis is typically based on symptoms and supported by blood tests, medical imaging, and analysis of cerebrospinal fluid. [2]

Certain types are preventable with vaccines. [5] Treatment may include antiviral medications (such as acyclovir), anticonvulsants, and corticosteroids. [1] Treatment generally takes place in hospital. [1] Some people require artificial respiration. [1] Once the immediate problem is under control, rehabilitation may be required. [2] In 2015, encephalitis was estimated to have affected 4.3 million people and resulted in 150,000 deaths worldwide. [3] [4]

Signs and symptoms

Adults with encephalitis present with acute onset of fever, headache, confusion, and sometimes seizures. Younger children or infants may present with irritability, poor appetite and fever. [7] Neurological examinations usually reveal a drowsy or confused person. Stiff neck, due to the irritation of the meninges covering the brain, indicates that the patient has either meningitis or meningoencephalitis. [8]

Cause

Rabies virus Rabies Virus EM PHIL 1876.JPG
Rabies virus

In 30%-40% of encephalitis cases, the etiology remains unknown. [9]

Viral

Viral infections are the usual cause of infectious encephalitis. [9] Viral encephalitis can occur either as a direct effect of an acute infection, or as one of the sequelae of a latent infection. The majority of viral cases of encephalitis have an unknown cause; however, the most common identifiable cause of viral encephalitis is from herpes simplex infection. [10] Other causes of acute viral encephalitis are rabies virus, poliovirus, and measles virus. [11]

Additional possible viral causes are arboviral flavivirus (St. Louis encephalitis, West Nile virus), bunyavirus (La Crosse strain), arenavirus (lymphocytic choriomeningitis virus), reovirus (Colorado tick virus), and henipavirus infections. [12] [13] The Powassan virus is a rare cause of encephalitis. [14]

Bacterial and other

It can be caused by a bacterial infection, such as bacterial meningitis, [15] or may be a complication of a current infectious disease such as syphilis (secondary encephalitis). [16]

Certain parasitic or protozoal infestations, such as toxoplasmosis, malaria, or primary amoebic meningoencephalitis, can also cause encephalitis in people with compromised immune systems. Lyme disease or Bartonella henselae may also cause encephalitis.[ citation needed ]

Other bacterial pathogens, like Mycoplasma and those causing rickettsial disease, cause inflammation of the meninges and consequently encephalitis. A non-infectious cause includes acute disseminated encephalitis which is demyelinated. [17]

Limbic encephalitis

Limbic encephalitis refers to inflammatory disease confined to the limbic system of the brain. The clinical presentation often includes disorientation, disinhibition, memory loss, seizures, and behavioral anomalies. MRI imaging reveals T2 hyperintensity in the structures of the medial temporal lobes, and in some cases, other limbic structures. Some cases of limbic encephalitis are of autoimmune origin. [18]

Autoimmune encephalitis

Autoimmune encephalitis signs can include catatonia, psychosis, abnormal movements, and autonomic dysregulation. Antibody-mediated anti-N-methyl-D-aspartate-receptor encephalitis and Rasmussen encephalitis are examples of autoimmune encephalitis. [19] Anti-NMDA receptor encephalitis is the most common autoimmune form, and is accompanied by ovarian teratoma in 58 percent of affected women 18–45 years of age. [20]

Encephalitis lethargica

Encephalitis lethargica is identified by high fever, headache, delayed physical response, and lethargy. Individuals can exhibit upper body weakness, muscular pains, and tremors, though the cause of encephalitis lethargica is not currently known. From 1917 to 1928, an epidemic of encephalitis lethargica occurred worldwide. [21]


Diagnosis

Spinal tap on a newborn Spinal tap newborn.JPG
Spinal tap on a newborn

People should only be diagnosed with encephalitis if they have a decreased or altered level of consciousness, lethargy, or personality change for at least twenty-four hours without any other explainable cause. [22] Diagnosing encephalitis is done via a variety of tests: [23] [24]

Prevention

Vaccination is available against tick-borne [25] and Japanese encephalitis [26] and should be considered for at-risk individuals. Post-infectious encephalomyelitis complicating smallpox vaccination is avoidable, for all intents and purposes, as smallpox is nearly eradicated. [27] Contraindication to Pertussis immunization should be observed in patients with encephalitis. [28]

Treatment

An ideal drug to treat brain infection should be small, moderately lipophilic at pH of 7.4, low level of plasma protein binding, volume of distribution of litre per kg, does not have strong affinity towards binding with P-glycoprotein, or other efflux pumps on the surface of blood–brain barrier. Some drugs such as isoniazid, pyrazinamide, linezolid, metronidazole, fluconazole, and some fluoroquinolones have good penetration to blood brain barrier. [29] Treatment (which is based on supportive care) is as follows: [30]

Pyrimethamine-based maintenance therapy is often used to treat toxoplasmic encephalitis (TE), which is caused by Toxoplasma gondii and can be life-threatening for people with weak immune systems. [31] The use of highly active antiretroviral therapy (HAART), in conjunction with the established pyrimethamine-based maintenance therapy, decreases the chance of relapse in patients with HIV and TE from approximately 18% to 11%. [31] This is a significant difference as relapse may impact the severity and prognosis of disease and result in an increase in healthcare expenditure. [31]

The effectiveness of intravenous immunoglobulin for the management of childhood encephalitis is unclear. Systematic reviews have been unable to draw firm conclusions because of a lack of randomised double-blind studies with sufficient numbers of patients and sufficient follow-up. [32] There is the possibility of a benefit of intravenous immunoglobulin for some forms of childhood encephalitis on some indicators such as length of hospital stay, time to stop spasms, time to regain consciousness, and time to resolution of neuropathic symptoms and fever. [32] Intravenous immunoglobulin for Japanese encephalitis appeared to have no benefit when compared with placebo (pretend) treatment. [32]

Prognosis

Identification of poor prognostic factors include cerebral edema, status epilepticus, and thrombocytopenia. [33] In contrast, a normal encephalogram at the early stages of diagnosis is associated with high rates of survival. [33]

Epidemiology

Encephalitis deaths per million persons in 2012 .mw-parser-output .legend{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .legend-color{display:inline-block;min-width:1.25em;height:1.25em;line-height:1.25;margin:1px 0;text-align:center;border:1px solid black;background-color:transparent;color:black}.mw-parser-output .legend-text{} 0-0 1-1 2-2 3-4 5-9 10-14 15-24 25-45 Encephalitis world map-Deaths per million persons-WHO2012.svg
Encephalitis deaths per million persons in 2012
  0-0
  1-1
  2-2
  3-4
  5-9
  10-14
  15-24
  25-45

The number of new cases a year of acute encephalitis in Western countries is 7.4 cases per 100,000 people per year. In tropical countries, the incidence is 6.34 per 100,000 people per year. [34] The number of cases of encephalitis has not changed much over time, with about 250,000 cases a year from 2005 to 2015 in the US. Approximately seven per 100,000 people were hospitalized for encephalitis in the US during this time. [33] In 2015, encephalitis was estimated to have affected 4.3 million people and resulted in 150,000 deaths worldwide. [4] [3] Herpes simplex encephalitis has an incidence of 2–4 per million of the population per year. [35]

Terminology

Encephalitis with meningitis is known as meningoencephalitis, while encephalitis with involvement of the spinal cord is known as encephalomyelitis. [2]

The word is from Ancient Greek ἐγκέφαλος, enképhalos 'brain', [36] composed of ἐν, en, 'in' and κεφαλή, kephalé, 'head', and the medical suffix -itis 'inflammation'. [37]

See also

Related Research Articles

<span class="mw-page-title-main">Acute disseminated encephalomyelitis</span> Autoimmune disease

Acute disseminated encephalomyelitis (ADEM), or acute demyelinating encephalomyelitis, is a rare autoimmune disease marked by a sudden, widespread attack of inflammation in the brain and spinal cord. As well as causing the brain and spinal cord to become inflamed, ADEM also attacks the nerves of the central nervous system and damages their myelin insulation, which, as a result, destroys the white matter. The cause is often a trigger such as from viral infection or vaccinations.

<span class="mw-page-title-main">West Nile fever</span> Human disease caused by West Nile virus infection

West Nile fever is an infection by the West Nile virus, which is typically spread by mosquitoes. In about 80% of infections people have few or no symptoms. About 20% of people develop a fever, headache, vomiting, or a rash. In less than 1% of people, encephalitis or meningitis occurs, with associated neck stiffness, confusion, or seizures. Recovery may take weeks to months. The risk of death among those in whom the nervous system is affected is about 10 percent.

<span class="mw-page-title-main">Viral meningitis</span> Medical condition

Viral meningitis, also known as aseptic meningitis, is a type of meningitis due to a viral infection. It results in inflammation of the meninges. Symptoms commonly include headache, fever, sensitivity to light and neck stiffness.

<span class="mw-page-title-main">Encephalitis lethargica</span> Form of encephalitis (sleeping sickness)

Encephalitis lethargica is an atypical form of encephalitis. Also known as "sleeping sickness" or "sleepy sickness", it was first described in 1917 by neurologist Constantin von Economo and pathologist Jean-René Cruchet. The disease attacks the brain, leaving some victims in a statue-like condition, speechless and motionless. Between 1915 and 1926, an epidemic of encephalitis lethargica spread around the world. The exact number of people infected is unknown, but it is estimated that more than one million people contracted the disease during the epidemic, which directly caused more than 500,000 deaths. Most of those who survived never recovered their pre-morbid vigour.

<span class="mw-page-title-main">Shingles</span> Viral disease caused by the varicella zoster virus

Shingles, also known as herpes zoster, is a viral disease characterized by a painful skin rash with blisters in a localized area. Typically the rash occurs in a single, wide mark either on the left or right side of the body or face. Two to four days before the rash occurs there may be tingling or local pain in the area. Other common symptoms are fever, headache, and tiredness. The rash usually heals within two to four weeks; however, some people develop ongoing nerve pain which can last for months or years, a condition called postherpetic neuralgia (PHN). In those with poor immune function the rash may occur widely. If the rash involves the eye, vision loss may occur.

<i>Enterovirus</i> Genus of viruses

Enterovirus is a genus of positive-sense single-stranded RNA viruses associated with several human and mammalian diseases. Enteroviruses are named by their transmission-route through the intestine.

<span class="mw-page-title-main">Aseptic meningitis</span> Medical condition

Aseptic meningitis is the inflammation of the meninges, a membrane covering the brain and spinal cord, in patients whose cerebral spinal fluid test result is negative with routine bacterial cultures. Aseptic meningitis is caused by viruses, mycobacteria, spirochetes, fungi, medications, and cancer malignancies. The testing for both meningitis and aseptic meningitis is mostly the same. A cerebrospinal fluid sample is taken by lumbar puncture and is tested for leukocyte levels to determine if there is an infection and goes on to further testing to see what the actual cause is. The symptoms are the same for both meningitis and aseptic meningitis but the severity of the symptoms and the treatment can depend on the certain cause.

<span class="mw-page-title-main">Neuritis</span> Inflammation of a nerve or generally any part of the nervous system

Neuritis, from the Greek νεῦρον), is inflammation of a nerve or the general inflammation of the peripheral nervous system. Inflammation, and frequently concomitant demyelination, cause impaired transmission of neural signals and leads to aberrant nerve function. Neuritis is often conflated with neuropathy, a broad term describing any disease process which affects the peripheral nervous system. However, neuropathies may be due to either inflammatory or non-inflammatory causes, and the term encompasses any form of damage, degeneration, or dysfunction, while neuritis refers specifically to the inflammatory process.

<span class="mw-page-title-main">Viral encephalitis</span> Medical condition

Viral encephalitis is inflammation of the brain parenchyma, called encephalitis, by a virus. The different forms of viral encephalitis are called viral encephalitides. It is the most common type of encephalitis and often occurs with viral meningitis. Encephalitic viruses first cause infection and replicate outside of the central nervous system (CNS), most reaching the CNS through the circulatory system and a minority from nerve endings toward the CNS. Once in the brain, the virus and the host's inflammatory response disrupt neural function, leading to illness and complications, many of which frequently are neurological in nature, such as impaired motor skills and altered behavior.

<span class="mw-page-title-main">Meningoencephalitis</span> Medical condition

Meningoencephalitis, also known as herpes meningoencephalitis, is a medical condition that simultaneously resembles both meningitis, which is an infection or inflammation of the meninges, and encephalitis, which is an infection or inflammation of the brain tissue.

<span class="mw-page-title-main">Mollaret's meningitis</span> Medical condition

Mollaret's meningitis is a recurrent or chronic inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges. Since Mollaret's meningitis is a recurrent, benign (non-cancerous), aseptic meningitis, it is also referred to as benign recurrent lymphocytic meningitis. It was named for Pierre Mollaret, the French neurologist who first described it in 1944.

The central nervous system (CNS) controls most of the functions of the body and mind. It comprises the brain, spinal cord and the nerve fibers that branch off to all parts of the body. The CNS viral diseases are caused by viruses that attack the CNS. Existing and emerging viral CNS infections are major sources of human morbidity and mortality.

<span class="mw-page-title-main">Meningitis</span> Inflammation of the membranes around the brain and spinal cord

Meningitis is acute or chronic inflammation of the protective membranes covering the brain and spinal cord, collectively called the meninges. The most common symptoms are fever, intense headache, vomiting and neck stiffness and occasionally photophobia.

<span class="mw-page-title-main">Herpes meningitis</span> Medical condition

Herpes meningitis is inflammation of the meninges, the protective tissues surrounding the spinal cord and brain, due to infection from viruses of the Herpesviridae family - the most common amongst adults is HSV-2. Symptoms are self-limiting over 2 weeks with severe headache, nausea, vomiting, neck-stiffness, and photophobia. Herpes meningitis can cause Mollaret's meningitis, a form of recurrent meningitis. Lumbar puncture with cerebrospinal fluid results demonstrating aseptic meningitis pattern is necessary for diagnosis and polymerase chain reaction is used to detect viral presence. Although symptoms are self-limiting, treatment with antiviral medication may be recommended to prevent progression to Herpes Meningoencephalitis.

<span class="mw-page-title-main">Herpes simplex encephalitis</span> Encephalitis associated with herpes simplex virus

Herpes simplex encephalitis (HSE), or simply herpes encephalitis, is encephalitis due to herpes simplex virus. It is estimated to affect at least 1 in 500,000 individuals per year, and some studies suggest an incidence rate of 5.9 cases per 100,000 live births.

Neurovirology is an interdisciplinary field which represents a melding of clinical neuroscience, virology, immunology, and molecular biology. The main focus of the field is to study viruses capable of infecting the nervous system. In addition to this, the field studies the use of viruses to trace neuroanatomical pathways, for gene therapy, and to eliminate detrimental populations of neural cells.

<span class="mw-page-title-main">Lymphocytic pleocytosis</span> Increase in lymphocytes within cerebrospinal fluid

Lymphocytic pleocytosis is an abnormal increase in the amount of lymphocytes in the cerebrospinal fluid (CSF). It is usually considered to be a sign of infection or inflammation within the nervous system, and is encountered in a number of neurological diseases, such as pseudomigraine, Susac's syndrome, and encephalitis. While lymphocytes make up roughly a quarter of all white blood cells (WBC) in the body, they are generally rare in the CSF. Under normal conditions, there are usually less than 5 white blood cells per µL of CSF. In a pleocytic setting, the number of lymphocytes can jump to more than 1,000 cells per µL. Increases in lymphocyte count are often accompanied by an increase in cerebrospinal protein concentrations in addition to pleocytosis of other types of white blood cells.

<span class="mw-page-title-main">Post-viral cerebellar ataxia</span> Medical condition

Post-viral cerebellar ataxia also known as acute cerebellitis and acute cerebellar ataxia (ACA) is a disease characterized by the sudden onset of ataxia following a viral infection. The disease affects the function or structure of the cerebellum region in the brain.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 "Meningitis and Encephalitis Information Page". NINDS. Archived from the original on 29 October 2017. Retrieved 29 October 2017.
  2. 1 2 3 4 5 6 7 8 9 10 "Meningitis and Encephalitis Fact Sheet". National Institute of Neurological Disorders and Stroke. Archived from the original on 29 October 2017. Retrieved 29 October 2017.
  3. 1 2 3 Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC   5055577 . PMID   27733282.
  4. 1 2 3 Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. (GBD 2015 Mortality and Causes of Death Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC   5388903 . PMID   27733281.
  5. 1 2 "Encephalitis". NHS Choices. 2016. Archived from the original on 22 September 2017. Retrieved 29 October 2017.
  6. ↑ Ellul M, Solomon T (March 2018). "Acute encephalitis - diagnosis and management". Clinical Medicine. 18 (2): 155–159. doi:10.7861/clinmedicine.18-2-155. PMC   6303463 . PMID   29626021.
  7. ↑ "Symptoms of encephalitis". NHS. Archived from the original on 5 January 2015. Retrieved 5 January 2015.
  8. ↑ Shmaefsky B, Babcock H (2010-01-01). Meningitis. Infobase Publishing. ISBN   978-1-4381-3216-7. Archived from the original on 2015-10-30.
  9. 1 2 "Encephalitis". www.hopkinsmedicine.org. 2021-08-08. Retrieved 2024-01-09.
  10. ↑ Roos KL, Tyler KL (2015). "Meningitis, Encephalitis, Brain Abscess, and Empyema". Harrison's Principles of Internal Medicine (19 ed.). New York, NY: McGraw-Hill Education. ISBN   978-0-07-180215-4. Archived from the original on 2017-11-17. Retrieved 2017-11-17.
  11. ↑ Fisher DL, Defres S, Solomon T (March 2015). "Measles-induced encephalitis". QJM. 108 (3): 177–182. doi: 10.1093/qjmed/hcu113 . PMID   24865261.
  12. ↑ Kennedy PG (March 2004). "Viral encephalitis: causes, differential diagnosis, and management". Journal of Neurology, Neurosurgery, and Psychiatry. 75 (Suppl 1): i10–i15. doi:10.1136/jnnp.2003.034280. PMC   1765650 . PMID   14978145. Archived from the original on 2015-10-02.
  13. ↑ Broder CC, Geisbert TW, Xu K, Nikolov DB, Wang LF, Middleton D, et al. (2012). "Immunization strategies against henipaviruses". Henipavirus. Current Topics in Microbiology and Immunology. Vol. 359. pp. 197–223. doi:10.1007/82_2012_213. ISBN   978-3-642-29818-9. PMC   4465348 . PMID   22481140.
  14. ↑ "Symptoms & Treatment | Powassan | CDC". www.cdc.gov. 4 December 2018. Archived from the original on 26 June 2019. Retrieved 26 June 2019.
  15. ↑ Ashar BH, Miller RG, Sisson SD (2012-01-01). Johns Hopkins Internal Medicine Board Review: Certification and Recertification. Elsevier Health Sciences. ISBN   978-1-4557-0692-1. Archived from the original on 2015-11-29.
  16. ↑ Hama K, Ishiguchi H, Tuji T, Miwa H, Kondo T (2008-01-01). "Neurosyphilis with mesiotemporal magnetic resonance imaging abnormalities". Internal Medicine. 47 (20): 1813–1817. doi: 10.2169/internalmedicine.47.0983 . PMID   18854635.
  17. ↑ Howes DS, Lazoff M, Conrad SA, Hemphill RR, Huff JS, Pritz T, et al. (2018-08-07). Brenner BE (ed.). "Encephalitis: Practice Essentials, Background, Pathophysiology". MedScape. Archived from the original on 2015-08-03.
  18. ↑ Larner AJ (2013-05-02). Neuropsychological Neurology: The Neurocognitive Impairments of Neurological Disorders. Cambridge University Press. ISBN   978-1-107-60760-6. Archived from the original on 2015-10-30.
  19. ↑ Armangue T, Petit-Pedrol M, Dalmau J (November 2012). "Autoimmune encephalitis in children". Journal of Child Neurology. 27 (11): 1460–1469. doi:10.1177/0883073812448838. PMC   3705178 . PMID   22935553.
  20. ↑ Dalmau J, Graus F (March 2018). "Antibody-Mediated Encephalitis". The New England Journal of Medicine. 378 (9): 840–851. doi:10.1056/NEJMra1708712. hdl: 2445/147222 . PMID   29490181. S2CID   3623281.
  21. ↑ encephalitis_lethargica at NINDS
  22. ↑ Venkatesan A, Tunkel AR, Bloch KC, Lauring AS, Sejvar J, Bitnun A, et al. (October 2013). "Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium". Clinical Infectious Diseases. 57 (8): 1114–1128. doi:10.1093/cid/cit458. PMC   3783060 . PMID   23861361.
  23. ↑ "Encephalitis: Diagnosis". NHS Choices. Archived from the original on 2015-07-16. Retrieved 2015-08-05.
  24. ↑ Kneen R, Michael BD, Menson E, Mehta B, Easton A, Hemingway C, et al. (May 2012). "Management of suspected viral encephalitis in children - Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group national guidelines". The Journal of Infection. 64 (5): 449–477. doi:10.1016/j.jinf.2011.11.013. PMID   22120594.
  25. ↑ "Tick-borne Encephalitis: Vaccine". International travel and health. World Health Organization. Archived from the original on 3 December 2013. Retrieved 2 April 2013.
  26. ↑ "Japanese encephalitis". Immunization, Vaccines and Biologicals. World Health Organization. Archived from the original on 3 December 2013. Retrieved 2 April 2013.
  27. ↑ "CDC Media Statement on Newly Discovered Smallpox Specimens". www.cdc.gov. January 2016. Archived from the original on 2016-05-20. Retrieved 2016-05-19.
  28. ↑ "Contraindications and Precautions to Commonly Used Vaccines in Adults". Vaccines. Center for Disease Control. Archived from the original on 2015-08-23. Retrieved 2015-08-05.
  29. ↑ Nau R, Sörgel F, Eiffert H (October 2010). "Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections". Clinical Microbiology Reviews. 23 (4): 858–883. doi:10.1128/CMR.00007-10. PMC   2952976 . PMID   20930076.
  30. ↑ MedlinePlus Encyclopedia : Encephalitis
  31. 1 2 3 Connolly MP, Goodwin E, Schey C, Zummo J (February 2017). "Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis". Pathogens and Global Health. 111 (1): 31–44. doi:10.1080/20477724.2016.1273597. PMC   5375610 . PMID   28090819.
  32. 1 2 3 Iro MA, Martin NG, Absoud M, Pollard AJ (October 2017). "Intravenous immunoglobulin for the treatment of childhood encephalitis". The Cochrane Database of Systematic Reviews. 2017 (10): CD011367. doi:10.1002/14651858.CD011367.pub2. PMC   6485509 . PMID   28967695.
  33. 1 2 3 Venkatesan A (June 2015). "Epidemiology and outcomes of acute encephalitis". Current Opinion in Neurology . 28 (3): 277–282. doi:10.1097/WCO.0000000000000199. PMID   25887770. S2CID   21041693.
  34. ↑ Jmor F, Emsley HC, Fischer M, Solomon T, Lewthwaite P (October 2008). "The incidence of acute encephalitis syndrome in Western industrialised and tropical countries". Virology Journal. 5 (134): 134. doi: 10.1186/1743-422X-5-134 . PMC   2583971 . PMID   18973679.
  35. ↑ Rozenberg F, Deback C, Agut H (June 2011). "Herpes simplex encephalitis : from virus to therapy". Infectious Disorders Drug Targets. 11 (3): 235–250. doi:10.2174/187152611795768088. PMID   21488834.
  36. ↑ "Woodhouse's English-Greek Dictionary" (in German). The University of Chicago Library. Archived from the original on 2017-03-05. Retrieved 2013-01-10.
  37. ↑ The word seems to have had a meaning of “lithic imitation of the human brain” at first, according to the Trésor de la langue française informatisé (cf. the article on “encéphalite” Archived 2017-11-05 at the Wayback Machine ). The first use in the medical sense is attested from the early 19th century in French (J. Capuron, Nouveau dictionnaire de médecine, chirurgie…, 1806), and from 1843 in English respectively (cf. the article “encephalitis” in the Online Etymology Dictionary). Retrieved 11 March 2017.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.